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Ste20 KinasesMaria Radu and Jonathan Chernoff*
When first reported in 1995, the mammalian Ste20-like
kinases (Mst) 1 and 2 were so named both for their simi-
larity to the yeast kinase Ste20 and for the fact that their
function was, to us, a deep mystery. While much remains
to be explained about the regulation and role of these
kinases, the veil has been at least partly raised on the
Msts, revealing unexpected modes of activation and func-
tion. Work in model organisms suggests a central growth-
suppressive role for Mst orthologs, with intriguing
possible links to other established tumor suppressors.
This minireview underlines our current understanding of
how Mst1 and Mst2 are regulated, and how activation of
these proteins influences cell survival and proliferation.
The mammalian Ste20-like kinases Mst1 and Mst2 are
closely related, evolutionarily conserved serine/threonine
protein kinases that play an important role in cell prolifera-
tion, survival, morphology, and motility. In Drosophila, the
Mst1/2 ortholog Hippo clearly has tumor suppressor activity,
and it is suspected, but not proven, that the mammalian Msts
may share this property. As such, the Msts have recently
become the subjects of intense scrutiny, yet we know rela-
tively little about how these kinases are regulated or the iden-
tity of their key substrates.
Mst: A Short History
Mst1 (also known as Stk4 and Krs2) and Mst2 (also known as
Stk3 and Krs1) were initially cloned from a lymphoid cDNA
library by PCR during a search for human relatives of
Saccharomyces cerevisiae Ste20 [1–3]. Subsequently, these
proteins were rediscovered by protein purification as
kinases that respond to extreme cellular stress [4]. Mst1
and 2 are closely related to one another and broadly ex-
pressed, but are structurally and functionally distinct from
Mst3 and Mst4, two other more distantly related kinases
with similar names, and from Ysk1/Sok1. Early biochemical
experiments revealed that the carboxyl terminus of Mst1
contains a coiled-coil dimerization motif, subsequently
termed the SARAH (Salvador, RASSF1, Hippo) domain,
which mediates self-association as well as association with
other SARAH-domain-containing proteins [5].
Physiological stimuli for the Msts, and the signaling path-
ways affected by these kinases, remained obscure until it
was realized that a w36 kDa protein kinase observed in
apoptotic cells was in fact an amino-terminal, caspase-
mediated cleavage product of Mst1 [6]. This finding provided
an important clue into both the regulation and the cellular
function of Mst1, linking it for the first time to a physiological
signaling process, namely apoptosis. Soon thereafter, cas-
pase-cleaved Mst1 was shown to shuttle from the cytosol
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matin condensation during apoptosis [7]. However, it was as
a result of discoveries made in Drosophila that a core
signaling activity of these kinases was first elucidated.
Here, genetic screens for flies with defects in organ size iden-
tified Hippo, the Mst1/2 ortholog, as a key regulator of cell
growth and survival [8,9]. Subsequent epistasis experiments
placed Hippo atop a tumor suppressor signaling pathway
involving the adaptor proteins Salvador (WW45, in man)
and MATS (Mob1), the protein kinase WARTS (Lats), and
the transcriptional coactivator Yorkie (Yap), which regulates
the expression of a number of cell proliferation and survival
genes. This model, well-described in a number of recent
reviews [10–12], forms the basis for our current under-
standing of Hippo function in flies and may well apply to
Mst function in man as well.
Mst Activation: Mysteries Still Abound
What activates the Msts? In flies, it has been suggested that
the ezrin–radixin–moesin proteins Merlin (a known tumor
suppressor in man) and Expanded lie upstream of Hippo.
Additional evidence that Merlin and Mst signaling are related
can be inferred from a recent report that shows increased
Yap expression and nuclear localization in Merlin-deficient
human meningioma cells, as well as rescue of cell-cycle
defects in such cells by siRNA-mediated silencing of Yap
expression [13–15]. What is missing, however, is any direct
evidence that Merlin associates with or affects the activity
of Mst. For these reasons it remains unclear whether Merlin
and Mst operate in series or in parallel signaling modules
that converge on a final common pathway. Clarifying the
relationship between Merlin and Mst is an important goal,
as Merlin remains one of the least understood of the classical
tumor suppressors and any success in tying the pathways
together could have important therapeutic implications.
What we do know about Mst activation can be summa-
rized in three words: cleavage, binding, and phosphorylation
(Figure 1). These three processes, alone or in combination,
play an important role in regulating Mst activity in a variety
of settings. At present, cleavage by caspase-3 remains the
best known and only mechanistically understood stimulus
for Mst. In this case, cleavage of the regulatory carboxyl
terminus liberates a fragment comprising the amino-terminal
kinase domain, which is nearly ten times more active than the
parent enzyme [16]. This cleavage also separates the amino-
terminal kinase domain from nuclear exclusion sequences
located in the carboxyl terminus, thus allowing the transloca-
tion of the kinase domain from the cytosol to the nucleus
and, presumably, offering it a different menu of substrates
to phosphorylate.
Proteolytic cleavage is not the sole mechanism of Mst acti-
vation, however. Full-length Mst is activated by staurospor-
ine (which is curious, as this is a general and potent kinase
inhibitor in most circumstances) as well as by other
apoptotic or stress stimuli, including UV radiation, tumor
necrosis factor a (TNFa), retinoic acid, serum starvation,
heat shock at 55C, hydrogen peroxide, reactive oxygen
species [16], and various anti-cancer drugs [16–18]. When
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multiple sites, including key threonine residues in the activa-
tion loop, which are likely to play a critical role in activating
the enzyme [19,20]. Mst is also negatively regulated by
phosphorylation. For example, Mst1 phosphorylation after
epidermal growth factor (EGF) stimulation results in
decreased kinase activity, while dephosphorylation in vitro
by protein phosphatase 2A (PP2A) restores kinase activity
[1]. In addition to activating and inhibiting Mst, phosphoryla-
tion can also regulate the sensitivity to cleavage as well as
the substrate specificity of Mst. In HEK293 cells, Jang et al.
[21] have shown that Akt-mediated phosphorylation of
Mst1 on Thr387 renders it resistant to cleavage by caspases,
less able to promote apoptosis, and less active towards the
pro-apoptotic transcription factor FOXO3, yet more active
towards histone H2B. These results are puzzling, as intact
Mst1 is mostly cytosolic, and therefore the cleavage-resis-
tant phosphorylated or phosphomimetic form would not be
expected to have access to nuclear H2B [22]. These results
could be interpreted to mean that the effects of Mst1 on
FOXO3 outweigh its effects on H2B, at least in terms of pro-
grammed cell death.
Finally, it is clear that Mst activity and/or function is regu-
lated by association with other proteins. In addition to form-
ing SARAH-domain-mediated homodimers, the Mst proteins
also heterodimerize with other SARAH-domain-containing
proteins. For example, Mst1 and Mst2 heterodimerize with
WW45 and with Nore1A/Nore1B, members of the RASSF
family of linker proteins that bind activated Ras and Rap
GTPases [23]. It appears that Mst–WW45 and Mst–Nore1
complexes are mutually exclusive, as no evidence for
a ternary Mst–WW45–Nore1 complex has been found
(although the same may not hold true for the related protein
Rassf1A, which is reported to co-precipitate with both
endogenous Mst2 and WW45 from HeLa cells) [23]. WW45
promotes Mst kinase activity and is itself a target of this
kinase [23]. The association of Nore1 with Mst, which is
thought to be constitutive, is required for Rap-mediated
‘inside-out’ integrin signaling in T cells. Here, activation of
Figure 1. Apoptotic signals lead to Mst acti-
vation by phosphorylation and proteolytic
cleavage.
Apoptotic stimuli lead to Mst autophosphory-
lation and activation of caspases. Autophos-
phorylated Mst is active and phosphorylates
substrates that amplify the apoptotic signal,
further increasing caspase activation. In addi-
tion, active caspases cleave off the Mst car-
boxy-terminal regulatory domain. This event
liberates the active amino-terminal kinase
domain, which translocates into the nucleus
where it phosphorylates transcription factors
and histones.
the small GTPase Rap1 results in the
recruitment of Nore1B (also known as
RapL), presumably as part of a Mst–
Nore1B complex. Mst1 is activated in
these circumstances, but not in
T cells that lack Nore1B or in cells ex-
pressing mutant forms of Nore1B that
cannot bind Mst1 [24]. Mst1 activation
plays a key role in T-cell development,
as Mst1-null mice show decreased numbers of naı¨ve
T cells, most likely due to the elimination of prematurely
activated T cells [24]. This function is consonant with the
general theme of Msts as negative regulators of cell growth
and survival. Mature T cells from Mst1-null mice also
showed defects in adhesion and motility [25]. Mst1 can in
addition bind to other members of the RASSF family,
including the aforementioned protein Rassf1A, which liber-
ates Mst from a complex with Raf (in which Mst is inactive)
[26] and brings Mst in proximity to active Ras at the plasma
membrane, where Mst becomes active [27]. In this case, the
meaning of the association between Mst and the adaptor
Rassf1A is less clear, as overexpression of Rassf1A has
been reported to have both stimulatory and inhibitory
effects on Mst activity [28]. Such apparently discordant
behavior is not unusual for adaptor proteins: too much
Rassf1A might sequester Mst and prevent its activation,
whereas lower amounts might assist in activation. Whatever
the exact nature of this interaction may be, both the Mst–
Nore1B and the Mst–Rassf1A associations link Msts with
upstream small GTPases, a theme common to several
members of the Ste20 superfamily of protein kinases,
such as the p21-activated kinases [29].
Mst Substrates
Despite the flurry of interest in the Msts that followed the
discovery of the Hippo tumor suppressor pathway in flies,
we know very little about the cellular substrates of Mst. In
fact, the total sum of known substrates is still a single digit
number (Figure 2). Nevertheless, even this small list reveals
several interesting facets of Mst function, especially with re-
gard to the role of Mst in promoting apoptosis and inhibiting
cell-cycle progression. For example, one of the best-charac-
terized mammalian substrates of Mst1 is H2B, which is phos-
phorylated at serine 14 in vitro and in apoptotic cells [30]. The
phosphorylation is catalyzed by the amino-terminal proteo-
lytic fragment of Mst1 that translocates into the nucleus.
Upon phosphorylation by Mst1, the Ser14-phosphorylated
form of H2B contributes to chromatin condensation and
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Figure 2. Multiple apoptotic signaling path-
ways are mediated by Mst targets.
Akt inhibits Mst kinase activity towards FOXO
transcription factors, but increases Mst
kinase activity towards H2B. In addition, Akt
can directly phosphorylate FOXO at a distinct
site (shown by the red circle), which results in
inhibition of apoptotic signaling. JNK is
a central player in Mst-mediated chromatin
condensation during apoptosis. Binding of
Nore1 to Mst brings Mst into proximity with
Ras. The Ras–Nore1–Mst complex is known
to be involved in mediating Ras-induced
apoptosis. Mst phosphorylates Mob1 and
promotes its binding to Lats, thereby stimu-
lating Lats phosphorylation. Mst also phos-
phorylates Lats, which ultimately results in
the phosphorylation of cytoplasmic Yap and
its translocation into the nucleus, where it
induces activation of pro-apoptotic transcrip-
tion factors.
DNA fragmentation, and thus to the
overall cell death program. However,
the importance of Mst-catalyzed, H2B
Ser14 phosphorylation to chromatin
condensation has been challenged by
reports that Mst1 also activates JNK,
and that activation of Mst1 does not
cause chromatin condensation or
apoptosis in embryonic stem cells
lacking the JNK activators Mkk4 and
Mkk7 [31]. These findings suggest
that it is caspase-mediated cleavage of Mst1, followed by
Mst1-mediated activation of the JNK pathway, rather than
direct H2B phosphorylation, that is the mechanism most
likely to be responsible for Mst-mediated induction of chro-
matin condensation during apoptosis. Alternatively, these
results may arise from cell-type specific differences.
The FOXO transcription factors represent a second class
of Mst substrates that is relevant to its pro-apoptotic effects.
When phosphorylated within the forkhead domain by Mst1,
FOXO3 can no longer bind 14-3-3. In the absence of 14-3-3
binding, FOXO3 is free to translocate to the nucleus, where
it activates a number of pro-apoptotic genes [32]. Interest-
ingly, the anti-apoptotic kinase Akt1 has been shown to
phosphorylate Mst1, preventing caspase cleavage of Mst1
and markedly decreasing Mst-mediated FOXO3 phosphory-
lation [21]. The relationship between Mst1 and Akt appears
to be mutually antagonistic, as might be expected for
a pro- and an anti-apoptotic kinase, respectively: Akt binds
to, phosphorylates, and inhibits Mst1, and Mst1 (and Mst2)
inhibits Akt, though it appears that this inhibition is due to
the association of these proteins rather than by phosphory-
lation of Akt by Mst. Recent experiments carried out in
neuronal cultures suggest that another member of FOXO
family, specifically FOXO1, is a substrate for Mst1 and that
this phosphorylation event facilitates FOXO1 translocation
into the nucleus by hindering the binding of 14-3-3 to
FOXO1. In such cells, Mst1–FOXO1 signaling appears to be
important in mediating neuronal death upon deprivation of
serum and of neuronal activity [33].
The AGC-family kinases Ndr1/2 and Lats1/2 are additional
substrates of Mst that contribute to apoptosis as well as cell-
cycle arrest. Both Fas-stimulated and okadaic-acid stimu-
lated phosphorylation and activation of Ndr1/2 are mediated
by Mst, which is present in a complex with Ndr and its co-
activator, Mob1 [34–36]. Similarly, Lats–Mob complexes,
key elements in the conserved Mst/Hippo pathway, are
phosphorylated and activated by Mst [37]. WW45 is required
for Mst binding to Lats and facilitates the phosphorylation of
Lats by Mst. Lats, in turn, phosphorylates and sequesters
Yap in the cytoplasm. Importantly, the related kinases Ndr1
and Ndr2 are unable to bind Yap or to phosphorylate Yap
in vitro. In mammals, cytoplasmic retention of the Yorkie
ortholog Yap leads to p73 stabilization and induction of
expression of the p53-inducible protein Puma, thus
promoting apoptosis and cell-cycle arrest [26]. It should be
noted that Mst achieves the same ends in Drosophila, but
by different means. In Drosophila, Hippo signaling through
Warts also leads to the phosphorylation of Yorkie and the
induction of apoptosis, but the genes regulated by Yorkie
are almost certainly different from those regulated by Yap
in mammalian cells. That is, active (unphosphorylated)
Yorkie upregulates the expression of the apoptosis inhibitor
dIAP, the cell-cycle protein cyclin E, and the microRNA
bantam [38,39]. With the possible exception of cyclin E
[13], the equivalents of these transcriptional targets are not
known to be affected by Yap in mammalian cells. Lats can
also regulate mitotic exit [40] by binding and inhibiting the
actin regulator LIM kinase [41], resulting in defective actin
polymerization and inhibition of cytokinesis.
DAP4 is a constitutively nuclear protein that homodimer-
izes through its amino terminus and binds Mst1 through
its carboxy-terminal region. DAP4 is not significantly
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kinase activity in vivo or in vitro. However, whereas overex-
pression of DAP4 does not cause apoptosis, coexpression
of DAP4 with Mst1 enhances Mst1-induced apoptosis
through a p53-dependent pathway. Mst1 is unable to directly
phosphorylate p53. DAP4 binds p53 and possibly brings
Mst1 in contact with p53, promoting apoptosis [42]. Interest-
ingly, DAP4 was initially identified as a possible mediator of
interferon g (IFNg)-induced apoptosis [43], but Mst proteins
fail to be activated in response to IFNg treatment.
Recently, Sun and colleagues [44] showed that cardiac
troponin is a substrate for Mst1. Phosphorylation by Mst1
resulted in conformational changes of cardiac troponin and
altered its interactions with other components of the
troponin complex. In the heart, activation of Mst causes car-
diomyocyte death and dilated cardiomyopathy, suggesting
an important role for Mst1 in regulation of cardiac muscle
contractility, probably by modulating signaling pathways
that control the myofilament function.
Concluding Remarks
Though we have learned a lot about the Msts, much about
these kinases remains obscure and, given the potential role
of Msts as tumor suppressors, these mysteries are too impor-
tant to leave unsolved. The major challenges are to uncover
the molecular links between cell-surface receptors and Mst
activation, to get a more complete picture of Mst substrates,
and to determine the functions of the two Mst isoforms in
mammalian organisms. Do Merlin and/or the human
Expanded homolog activate Mst, and, if so, how? Is this
pathway related to or independent of small GTPase/RASSF1
inputs? Regarding the issue of Mst substrates, we need not
wait for the next genetic screen in flies; several new bioinfor-
matic and biochemical tools are available that might speed
up the hunt in mammalian cells. For example, phosphopro-
teomic methods have revealed the optimal (and highly
unusual) phosphorylation consensus site preferred by
Mst1/2 — WYNTMKRR [45] — and this information, encoded
in matrix form, could be used to search databases of known
phosphopeptides to predict new Mst substrates. In addition,
new unbiased schemes to detect direct substrates for protein
kinases [46,47] could and should be brought to bear on this
problem. At the level of biochemistry, we know little about
the interplay, if any, between Mst1 and Mst2. Do the two
Msts form heterodimers, and, if so, is the regulation, location,
function, and/or substrate specificity of such heterodimers
different from Mst homodimers? In addition, much remains
to be learned about Mst genetic functions in mammals. Are
Mst1 and Mst2 redundant in mammals, or do they serve
unique functions? Are either of these kinases tumor suppres-
sors? Hypermethylation of the Mst1 and Mst2 promoters
have been shown to inhibit the WW45–Rassf1–Mst pathway
in human sarcomas [48] and loss of cytoplasmic Mst1 has
been reported to be a marker for tumor progression in colo-
rectal cancer, suggesting that Mst1 can function as a tumor
suppressor [49]. However, the Mst1 knockout mouse is
reported to have a surprisingly mild phenotype and does
not appear, on its own, to have tumor suppressor function
[25,50]. Whether Mst2, which can replace Hippo function in
flies, will have such activity is not known. These and related
questions will keep us busy for some time, but it is to be
hoped that solving the mystery of the Msts will have a bearing
on our evolving understanding of how cells regulate their
proliferation and survival.References
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